RAMSEY, N.J. and BOCA RATON, Fla., April 01, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the…
Experimental trial research presented at the American College of Cardiology’s 71st Annual Scientific Session showed that the combinations of EPA/atorvastatin…
HOUSTON, April 01, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to…
NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider…
Philogen Reports Full Year 2021 Results and Provides Corporate Update Patient enrolment in Nidlegy™’s European Phase III trial for the…
CAMBRIDGE, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company using translational bioinformatics to advance…
Company announcement no. 4 - 221 April 2022 Reporting of transactions made by persons discharging managerial responsibilities and persons closely…
COPENHAGEN, Denmark, April 1, 2022 – In accordance with the Company’s remuneration policy, the Board of Directors of Bavarian…
KODEX-EPD cardiac imaging and mapping system from Philips Philips KODEX-EPD cryoballoon procedure Philips GlideLight Laser Sheath for lead management Philips…
Press release (MAR)Malmö, Sweden, April 1, 2022 FDA requests supplementary information for Acarix breakthrough designation request for heart failure diagnosis The Food and…